Five Years Follow-Up after 2-Chloro Deoxyadenosine Treatment in Thirty Patients with Hairy Cell Leukemia: Evaluation of Minimal Residual Disease and CD4+ Lymphocytopenia after Treatment

References

• Flandrin G, Sigaux F, Sebahoun G, Bouffette P. Hairy cell leukemia: Clinical presentation and follow up of 211 patients. Semin Oncol 1984; 11: 333
   Google Scholar
• Golomb H M, Ratain M J, Mick R, Daly K. Interferon treatment for hairy cell leukemia: An update on a cohort of 69 patients treated from 1983–1986. Leukemia 1992; 6: 1177
   PubMed Web of Science ®Google Scholar
• Troussard X, Flandrin G. Hairy cell leukemia. An update on a cohort of 93 patients treated in a single institution. Effects of interferon in patients relapsing ater splenectomy and in patients with or without maintenance treatment. Leukemia and Lymphoma 1994; 14(suppl. 1)99–105
   PubMed Web of Science ®Google Scholar
• Piro L D, Carrera C J, Beutler E, Carson D A. Lasting remissions induced by a single infusion of 2 chlorodeoxyadenosine. N Engl J Med 1990; 322: 11–17
   Web of Science ®Google Scholar
• Estey E H, Kurzrock R, Kantarjian H M, O'Brien S M, McCredie K B, Beran M, Koler C, Keating M J, Hirsch-Ginsberg C, Huh Y O, Stass S, Freireich E J. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine. Blood 1992; 79: 882
   PubMed Web of Science ®Google Scholar
• Juliusson G, Liliemark J. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): Relation to opportunistic infections. Blood 1992; 79: 888–894
   PubMed Web of Science ®Google Scholar
• Tallman M S, Hakimian D, Variakojis D, Koslow D, Sisney G A, Rademaker A W, Rose E, Kaul K. A single cycle of 2-Chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood 1992; 80: 2203
   PubMed Web of Science ®Google Scholar
• Al T Saati, Caspar S, Brousset P, Chittal S M, Caveriviere P, Hounieu H, Dastugue N, Idoipe J-B, Icart J, Mazerolles C, Delsol G. Production of anti-B monoclonal antibodies (DBB.42, DBA.44, DNA.7, and DND.53) reactive on parrafin-embedded tissues with a new B-lymphoma cell line grafted into athymic nude mice. Blood 1989; 74: 2476
   PubMed Web of Science ®Google Scholar
• Hounieu H, Chittal S M, Al T Saati, De Mascarel A, Sabattini E, Pileri S, Ralfkiaer E, Le Tourneau A, Selves J, Voigt J J, Laurent G, Diebold J, Delsol G. Hairy cell leukemia. Diagnosis of bone marrow involvement in parrafin-embedded sections with monoclonal antibody DBA44. Am J Clin Pathol 1992; 98: 26
   PubMed Web of Science ®Google Scholar
• Seymour J F, Kurzrock R, Freireich E J, Estey E H. 2-Chlorodeoxyadenosine induces durable remissons and prolonged supression of CD4+ lymphocyte counts in patients with hairy cell leukemia. Blood 1994; 83: 2906–2911
   PubMed Web of Science ®Google Scholar
• Hoffman M, Janson D, Rose E, Rai K R. Treatment of hairy cell leukemia with cladribine. J Clin Oncol 1997; 84: 4061
   Google Scholar
• Tallman M S, Hakimian D, Zanzig C, Rademaker A W, Wollins E, Peterson L C. Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience. Blood 1996; 88: 1954
   PubMed Web of Science ®Google Scholar
• Saven A, Burian C, Koziol J A, Piro D. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood 1998; 92: 1918
   PubMed Web of Science ®Google Scholar
• Cheson B D, Mel J Sorensen, Vena D A, Montello M J, Barrett J A, Damasio E, Tallman M, Annino L, Connors J, Coiffier B, Lauria F. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients. J Clin Oncol 1998; 16: 3007
   PubMed Web of Science ®Google Scholar
• Catovsky D, Matutes E, Talavera J G, O'Connor N T J, Johnson S A N, Emmett E, Corbett L, Swansbury J. Long term results with 2'Deoxycoformycin in hairy cell leukemia. Leukemia Lymph 1994; 14(suppl. 1)109–113
   PubMed Web of Science ®Google Scholar
• Kraut E H, Grever M R, Bouroncle B A. Long-term follow-up of patients with hairy ceil leukemia after treatment with 2'-Deoxycoformycin. Blood 1994; 84: 4061
   PubMed Web of Science ®Google Scholar
• Ellison D J, Sharpe R W, Robbins B A, Spinosa J C, Leopard J D, Saven A, Piro L D. Immunomorphologic analysis of bone marrow biopsies after treatment with 2-Chlorodeoxyadenosine for hairy cell leukemia. Blood 1994; 84: 4310
   PubMed Web of Science ®Google Scholar
• Tallman M, Hakimian D, Wheaton S, Kopecky K, Wollins E, Foucar K, Cassileth P, Habermann T, Grever M, Peterson L C. Minimal residual disease in patients with hairy cell leukemia in complete remission: Comparison of 2-chlorodeoxyadenosine with 2-deoxycoformycin and prediction of early relapse. Blood 1995; 86(suppl 1)351a
   Google Scholar
• Filleul B, Delannoy A, Ferrant A, Zenzbzrg A, Van Daele S, Bosly A, Doyen C, Mineur P, Glorieux P, Driesschaert P, Sokal G, Martiat P, Michaux J L. A single course of 2-chlorodeoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission. Leukemia 1994; 8: 1153
   PubMed Web of Science ®Google Scholar
• Raemaekers J, Vt M Veer, Verhoef G, Huijgens P, Sonneveld P, d Bock B, Oers R, Marwijk-Kooy R, Bogman J. Two-hours I. V infusion of 2-chlorodeoxyadenosine in hairy cell leukemia is effective and may produce less CD4/CD8 ratio impairment. Results from the Hovon-23 study. Blood 1995; 86(suppl 1)351a, no 1392
   Google Scholar
• Meunier Ph, Castaigne S, Bastie J N, Chosidow O, Aractingi S. Cutaneous reactions after treatment with 2-Chlorodeoxyadenosine. Acta Derm Venereol 1996; 76: 385
   PubMed Web of Science ®Google Scholar
• Seymour J F, Talpaz M, Kurzrock R. Splenectomized patients have more rapid recovery of CD4+ lymphocytes following deoxycoformycin: long-term follow-up of patients with hairy cell leukemia resistant to interferon. Blood 1995; 86(suppl 1)351a, no 1391
   Google Scholar
• Urba W J, Baseler W C, Steis R G, Clark J W, Smith J Wh, Coggin D L, Long D L. Deoxycoformycin induced immunosupression in patients with hairy cell leukemia. Blood 1989; 73: 38
   PubMed Web of Science ®Google Scholar
• Jacobs R H, Vokes E E, Golomb H M. Second malignancies in hairy cell leukemia. Cancer 1985; 56: 1642–1647
   Google Scholar
• Kampmeier P, Spielberger R, Dickstein J, Mick R, Golomb H, Vardiman J W. Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment. Blood 1994; 83: 2931
   PubMed Web of Science ®Google Scholar
• Frassoldati A, Lamparelli T, Federico M. Hairy cell leukemia: a clinical review based on 725 cases of the Italian Cooperative Group (ICGHCL). Leuk Lymph 1994; 13: 307–316
   PubMed Web of Science ®Google Scholar